[1]
|
GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC CancerBase No. 10.
http://globocan.iarc.fr.
|
[2]
|
Lehtinen, M., Pawlita, M., Zumbach, K., et al. (2003) Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. American Journal of Obstetrics & Gynecology, 188, 49-55. doi:10.1067/mob.2003.98
|
[3]
|
Nanda, K., McCrory, D.C., Myers, E.R., et al. (2000) Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Annals of Internal Medicine, 132, 810-819.
doi:10.1111/j.1526-0976.2001.51012-12.pp.x
|
[4]
|
Siebers, A.G., Klinkhamer, P.J., Grefte, J.M., et al. (2009) Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: A randomized controlled tral. Journal of the American Medical Association, 302, 1757-1764.
doi:10.1001/jama.2009.1569
|
[5]
|
Ronco, G., Cuzick, J., Pierotti, P., et al. (2007) Accuracy of liquid based versus conventional cytology: Overall results of new technologies for cervical cancer screening: Randomised controlled trial. British Medical Journal, 335, 28. doi:10.1136/bmj.39196.740995.BE
|
[6]
|
An, H.J., Kim, K.R., Kim, I.S., et al. (2005) Prevalence of human papillomavirus DNA in various histological subtypes of cevical adenocarcinoma: A population-based study. Modern Pathology, 18, 528-534.
doi:10.1038/modpathol. 3800316
|
[7]
|
Kitchener, H.C., Almonte, M., Gilham, C. et al. (2009) ARTISTIC: A randomised trial of human papillomavirus (HPV) testing in primary cervical screening. Health Technology Assessment, 13, 1-150, doi:10.3310/hta13510
|
[8]
|
Grce, M. and Davies, P. (2008) Human papillomavirus testing for primary cervical cancer screening. Expert Review of Molecular Diagnostics, 8, 599-605.
doi:10.1016/S0140-6736(07)61480-9
|
[9]
|
Cuzick, J., Clavel, C., Petry, K.U., et al. (2006) Overview of the European and North American studies on HPV testing in primary cervical cancer screening. International Journal of Cancer, 119, 1095-1101.
doi:10.1002/ijc.21955
|
[10]
|
Hopman, A.H., Theelen, W., Hommelberg, P.P., et al. (2006) Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. Journal of Pathology, 210, 412-419. doi:10.1002/path.2070
|
[11]
|
Zhao, J.Q., Glasspool, R.M., Hoare, S.F., et al. (2000) Activation of telomerase rna gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3. Neoplasia, 2, 531-539.
doi:10.1038/sj.neo.7900114
|
[12]
|
Kokalj-Vokac, N., Kodric, T., Erjavec-Skerget, A., Zagorac, A. and Takac, I. (2009) Screening of TERC gene amplification as an additional genetic diagnostic test in detection of cervical preneoplastic lesions. Cancer Genetics and Cytogenetics, 195, 19-22.
doi:10.1016/j.cancergencyto.2009.01.005
|
[13]
|
Zheng, L., Liu, A.L., Qi, T., et al. (2010) Human telomerase RNA gene amplification detection increases the specificity of cervical intraepithelial neoplasia screening. International Journal of Gynecological Cancer, 20, 912-917. doi:10.1111/IGC.0b013e3181e5c424
|
[14]
|
Heselmeyer-Haddad, K., Janz, V., Castle, P.E., et al. (2003) Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. American Journal of Pathology, 163, 1405-1416.
doi:10.1016/S0002-9440(10)63498-0
|
[15]
|
Andersson, S., Sowjanya, P., Wangsa, D., et al. (2009) Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears. American Journal of Pathology, 175, 1831-1847.
doi:10.2353/ajpath.2009.090122
|
[16]
|
Mahon, M.M., Cox, I.J., Dina, R., et al. (2004) (1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: In vivo-ex vivo profiles and effect of tumor load. Journal of Magnetic Resonance Imaging, 19, 356-364. doi:10.1002/jmri.20012
|
[17]
|
Tu, Z., Zhang, A., Wu, R., et al. (2009) Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders. Cancer Genetics and Cytogenetics, 91, 10-16.
doi:10.1016/j.cancergencyto.2009.01.004
|
[18]
|
Akobeng, A.K. (2007) Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta Paediatrica, 96, 644-647.
doi:10.1111/j.1651-2227.2006.00178.x
|
[19]
|
Olaharski, A.J., Sotelo, R., Solorza-Luna, G., et al. (2006) Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis, 27, 337-343. doi:10.1093/carcin/bgi218
|
[20]
|
Caraway, N.P., Khanna, A., Dawlett, M., et al. (2008) Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. Gynecologic Oncology, 110, 37-42. doi:10.1016/j.ygyno.2008.01.040
|
[21]
|
Oikonomou, P., Mademtzis, I., Messinis, I., Tsezou, A. (2006) Quantitative determination of human telomerase reverse transcriptase messenger RNA expression in premalignant cervical lesions and correlation with human papillomavirus load. Human Pathology, 37, 135-142.
doi:10.1016/j.humpath.2005.09.031
|
[22]
|
Sui, W., Ou, M., Dai, Y., et al. (2009) Gain of the human telomerase RNA gene TERC at 3q26 is strongly associated with cervical intraepithelial neoplasia and carcinoma. International Journal of Gynecological Cancer, 19, 1303-1306. doi:10.1111/IGC.0b013e3181b62ea5
|
[23]
|
Li, Y., Ye, F., Lu, W.G., Zeng, W.J., Wei, L.H. and Xie, X. (2010) Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: Comparison with cytological and human papillomavirus DNA test findings. International Journal of Gynecological Cancer, 20, 631-637. doi:10.1111/IGC.0b013e3181c50c7e
|
[24]
|
Heselmeyer-Haddad, K., Sommerfeld, K., White, N.M., et al. (2005) Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer. American Journal of Pathology, 166, 1229-1238.
doi:10.1016/S0002-9440(10)62341-3
|
[25]
|
Yugawa, T. and Kiyono, T. (2009) Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: Novel functions of E6 and E7 oncoproteins. Reviews in Medical Virology, 19, 97-113.
doi:10.1002/rmv.605
|
[26]
|
Takac, I., Arko, D., Kodric, T., et al. (2009) Human telomerase gene amplification and high-risk human papillomavirus infection in women with cervical intra-epithelial neoplasia. Journal of International Medical Research, 37, 1588-1595.
doi:10.1111/IGC.0b013e3181e5c
|